| Barbara Ann Hargiss, | |
|
1085 Maple St, Farmington, MO 63640-1955 | |
| (573) 756-5353 | |
| Not Available |
| Full Name | Barbara Ann Hargiss |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1085 Maple St, Farmington, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063784601 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Ann Hargiss, 1085 Maple St, Farmington, MO 63640-1955 Ph: (573) 756-5353 | Barbara Ann Hargiss, 1085 Maple St, Farmington, MO 63640-1955 Ph: (573) 756-5353 |
News Archive
When tested in brain cells and in a mouse model of Alzheimer's disease, a new compound significantly reduced the number of amyloid plaques in the brain, lessened brain inflammation and diminished other molecular markers of the disease.
In the course of doing research on the mosquito-borne pathogens chikungunya virus (CHIKV) and o' nyong-nyong virus (ONNV), Virginia Tech researchers have discovered an inconvenient truth about an assay, strand-specific quantitative real-time PCR (ssqPCR), increasingly being used to detect and measure replicating viral RNA in infected cells and tissues. The method most labs are using for ssqPCR is unreliable.
Safeguard Scientifics, Inc. today announced fourth quarter and full-year 2013 financial results. For the three months ended December 31, 2013, Safeguard's net income was $24.0 million, or $1.10 per share, compared to net loss of $10.8 million, or $0.51 per share for the same period in 2012. For the year ended December 31, 2013, Safeguard's net loss was $35.5 million, or $1.66 per share, compared to $39.4 million, or $1.88 per share for the same period in 2012.
Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy agent had longer survival than patients treated with the standard targeted drug, said an investigator from Dana-Farber Cancer Institute, reporting results from a phase 3 clinical trial.
At the London launch of a Lancet series on non-communicable diseases (NCDs) on Monday, U.N. Development Programme Administrator Helen Clark said if NCDs are placed "permanently on the global development agenda, people's lives, opportunities, and future prospects will improve - thereby advancing sustainable human development overall," Devex's "Development Newswire" blog reports.
› Verified 6 days ago
Mrs. Wenona H Mickan, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1085 Maple St, Farmington, MO 63640 Phone: 573-747-2438 | |
Mrs. Julie Ann Downs, MSW/LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 118 West Pine Plaza, Farmington, MO 63640 Phone: 573-701-0330 Fax: 573-701-0330 | |
Deborah Lynn Bonham, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1269 Doctors Dr, Farmington, MO 63640 Phone: 573-664-1146 Fax: 573-664-1149 | |
Rachael Christine Holloway, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1085 Maple St, Farmington, MO 63640 Phone: 573-756-5353 | |
William Jeffrey Jones, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1085 Maple St, Farmington, MO 63640 Phone: 573-756-5353 | |
Misty Dawn Fowler, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1085 Maple St, Farmington, MO 63640 Phone: 573-366-4659 | |
Mrs. Melissa L. Black, MSW/LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 118 West Pine Plaza, Farmington, MO 63640 Phone: 573-701-0330 Fax: 573-701-0330 |